Stay up to date and read about our most recent milestones towards achieving CENTOGENE’s mission: To enable the cure of 100 rare diseases in 10 years.
Interested in receiving the latest news around the clock? Follow us on LinkedIn.
CENTOGENE Reports Full Year 2022 Financial Results
CENTOGENE to Participate in Upcoming Conferences in May
CENTOGENE Receives Nasdaq Non-Compliance Notice
CENTOGENE Accelerates Global Genetic Data Interpretation, Launching FilterTool Application as Accessory to CentoCloud® Bioinformatics Pipeline
CENTOGENE to Participate in Upcoming Conferences in April
CENTOGENE Launches NEW CentoGenome®, World’s Most Comprehensive Whole Genome Sequencing Solution for Diagnosis of Rare and Neurodegenerative Diseases
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
IQVIA and CENTOGENE Form Collaboration to Improve Health Outcomes for Rare Disease Patients
CENTOGENE Appoints Ian Rentsch as Chief Commercial Officer and General Manager - Pharma
CENTOGENE to Participate in Upcoming Conferences in March
For Further Inquiries Please Contact
Here you can find forms, brochures, flyer and information sheets for download (PDF) about the broad genetic testing product and service portfolio of CENTOGENE.